Risk of venous thromboembolism with third-generation oral contraceptives: A review

This publication has 7 references indexed in Scilit:

• Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second‐ and third‐generation oral contraceptives
  British Journal of Haematology, 1997
• The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational research
  Contraception, 1996
• Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study
  BMJ, 1996
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease
  The Lancet, 1995
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components
  The Lancet, 1995
• Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen
  The Lancet, 1995
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study
  The Lancet, 1995